Mammograms and Older Women: Is It Ever Safe to Stop?
Mammograms are a very important part of follow-up care in women with breast cancer. But what about older women? How long should they continue to receive mammograms?
Mammograms are a very important part of follow-up care in women with breast cancer. But what about older women? How long should they continue to receive mammograms?
In this month’s From the Editor’s Desk, Dr. Schapira writes about prevention and what we can do to help understand and manage our personal cancer risk.
One of the studies that will be presented at the Gastrointestinal Cancers Symposium this week has found that a liquid biopsy test can accurately find early-stage colorectal cancer.
In this Voices on Cancer blog post, prostate cancer advocate Dennis Golden describes his cancer experience and how he put his professional skills to work advancing his advocacy mission.
Thinking about taking an at-home genetic test? In this podcast, Dr. Nadine Tung provides her expert insight on the advantages and disadvantages of these tests.
Researchers are using genetic information to find a woman’s risk for breast cancer. Dr. Kurian writes about how this knowledge affects screening and prevention strategies for breast cancer.
April is Testicular Cancer Awareness Month. Survivor and advocate Connor O’Leary reveals what he wishes he had known about the disease.
With the varied recommendations surrounding breast cancer screening, how do women sort through the information and make good decisions for their health? In this interview, Connie Lehman, MD, PhD, helps decipher the recommendations for screening mammography.
What is low dose CT screening for lung cancer? What are the benefits and risks? Should I ask my doctor about it? In this podcast, Dr. Bernardo Goulart answers these questions and more.
Get highlights of four studies that address ways to improve the care of men with prostate cancer. Results include the identification of a potential risk factor, better ways to select the best treatment option, and new insight into the debate over prostate-specific antigen (PSA) screening.